Lessons From a Pharma
MR Veteran: High & Low
Points, Challenges &
Solutions for Our Profession
PBIRG Perspective, February 2007

Interested in learning more about your chosen career path in pharmaceutical marketing research? Get the perspective of someone who has been “around the block” a few times. Richard B. Vanderveer, Ph.D., Group CEO of the GfK U.S. Healthcare Companies, was recently invited by the Pharmaceutical Business Intelligence and Research Group (PBIRG) to share his thoughts as a veteran pharmaceutical marketing researcher in a Q&A format interview titled, Enlightened by a Luminary, for PBIRG’s membership newsletter, Perspective.

What are the most important high points, or positive changes, witnessed by pharmaceutical marketing researchers over the past decades? Conversely, what are low points or “decisions-gone-wrong” that have had a negative impact on our profession? What are the biggest challenges facing marketing researchers in the current environment and what are some proposed solutions to get past these hurdles? How can you, individually, and our profession, collectively, contribute in the coming years to making a significant impact on the pharmaceutical industry?

Dr. Vanderveer opines on these and other topics in this informal discussion with Merck’s Evlogi Itsev, Chair of the PBIRG Public Relations Committee.

To download the full article titled, Enlightened by a Luminary: An Interview with Richard B. Vanderveer, Ph.D., please click here.


Want to learn more on this topic? Please contact: